Burton DR - Search Results

1

Antibody 2G12 recognizes di-mannose equivalently in domain- and nondomain-exchanged forms but only binds the HIV-1 glycan shield if domain exchanged.

Doores KJ, Fulton Z, Huber M, Wilson IA, Burton DR. Doores KJ, et al. Among authors: burton dr. J Virol. 2010 Oct;84(20):10690-9. doi: 10.1128/JVI.01110-10. Epub 2010 Aug 11. J Virol. 2010. PMID: 20702629 Free PMC article.

2

Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing abilities to neutralize human immunodeficiency virus type 1.

Roben P, Moore JP, Thali M, Sodroski J, Barbas CF 3rd, Burton DR. Roben P, et al. Among authors: burton dr. J Virol. 1994 Aug;68(8):4821-8. doi: 10.1128/JVI.68.8.4821-4828.1994. J Virol. 1994. PMID: 7518527 Free PMC article.

3

Protection against HIV-1 infection in hu-PBL-SCID mice by passive immunization with a neutralizing human monoclonal antibody against the gp120 CD4-binding site.

Parren PW, Ditzel HJ, Gulizia RJ, Binley JM, Barbas CF 3rd, Burton DR, Mosier DE. Parren PW, et al. Among authors: burton dr. AIDS. 1995 Jun;9(6):F1-6. doi: 10.1097/00002030-199506000-00001. AIDS. 1995. PMID: 7662189

4

Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody.

Burton DR, Pyati J, Koduri R, Sharp SJ, Thornton GB, Parren PW, Sawyer LS, Hendry RM, Dunlop N, Nara PL, et al. Burton DR, et al. Science. 1994 Nov 11;266(5187):1024-7. doi: 10.1126/science.7973652. Science. 1994. PMID: 7973652

5

In vitro evolution of a neutralizing human antibody to human immunodeficiency virus type 1 to enhance affinity and broaden strain cross-reactivity.

Barbas CF 3rd, Hu D, Dunlop N, Sawyer L, Cababa D, Hendry RM, Nara PL, Burton DR. Barbas CF 3rd, et al. Among authors: burton dr. Proc Natl Acad Sci U S A. 1994 Apr 26;91(9):3809-13. doi: 10.1073/pnas.91.9.3809. Proc Natl Acad Sci U S A. 1994. PMID: 8170992 Free PMC article.

6

Protection of nude mice by passive immunization with a type-common human recombinant monoclonal antibody against HSV.

Sanna PP, De Logu A, Williamson RA, Hom YL, Straus SE, Bloom FE, Burton DR. Sanna PP, et al. Among authors: burton dr. Virology. 1996 Jan 1;215(1):101-6. doi: 10.1006/viro.1996.0011. Virology. 1996. PMID: 8553581 Free article.

7

In vitro antigen challenge of human antibody libraries for vaccine evaluation: the human immunodeficiency virus type 1 envelope.

Parren PW, Fisicaro P, Labrijn AF, Binley JM, Yang WP, Ditzel HJ, Barbas CF 3rd, Burton DR. Parren PW, et al. Among authors: burton dr. J Virol. 1996 Dec;70(12):9046-50. doi: 10.1128/JVI.70.12.9046-9050.1996. J Virol. 1996. PMID: 8971041 Free PMC article.

8

Human immunodeficiency virus type 1 mutants that escape neutralization by human monoclonal antibody IgG1b12. off.

Mo H, Stamatatos L, Ip JE, Barbas CF, Parren PW, Burton DR, Moore JP, Ho DD. Mo H, et al. Among authors: burton dr. J Virol. 1997 Sep;71(9):6869-74. doi: 10.1128/JVI.71.9.6869-6874.1997. J Virol. 1997. PMID: 9261412 Free PMC article.

9

Erratum to "Relevance of the antibody response against human immunodeficiency virus type 1 envelope to vaccine design".

Parren PW, Gauduin MC, Koup RA, Poignard P, Sattentau QJ, Fisicaro P, Burton DR. Parren PW, et al. Among authors: burton dr. Immunol Lett. 1997 Jul;58(2):125-32. doi: 10.1016/s0165-2478(97)00109-0. Immunol Lett. 1997. PMID: 9271324 Review.

10

A vaccine for HIV type 1: the antibody perspective.

Burton DR. Burton DR. Proc Natl Acad Sci U S A. 1997 Sep 16;94(19):10018-23. doi: 10.1073/pnas.94.19.10018. Proc Natl Acad Sci U S A. 1997. PMID: 9294155 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

670 results

Search Page

Filters